Zai Lab unveils early lung cancer data as it looks to challenge Amgen's Imdelltra
Zai Lab released Phase 1a data Thursday morning as it attempts to compete with a recently approved Amgen drug.
The program, known as ZL-1310, induced …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
